Swiss HLG

Join us for our annual after work networking event in Swiss Romandie in collaboration with Biopôle Lausanne and BioAlps - Swiss Health Valley on October 3rd at Biopôle in Lausanne. 🗣️There will be a panel discussion with speakers: Raluca Flükiger, Vincent Ossipow, Sergio Capancioni and Madiha Derouazi on the theme “Negotiations: Aligning stakeholders to success” with representatives from start-up, academia, pharma and venture capital. The panel will be followed by a networking apero. 👉Register here ➡https://lnkd.in/eHiJuaFb We look forward to seeing you there!

Registration is now open for the ever-popular IPLS pre-CPHI networking drinks reception - take advantage of the early bird rate and register now! #IPLS #SwissHLG #networking #dealmaking #CPHI #healthcare

Interested in learning more about dealmaking? The UK PLG Introduction to Healthcare Business Development training course is an intensive training course run across 3 full days covering the key elements of Licensing and Business Development. It comprises 10 essential topics delivered by a faculty of experienced business development practitioners in their chosen area and provides guidance on best practice using case study material. The course also includes a hands-on example of negotiating a deal. It takes place in London on 20-22 November 2024. More info here: https://lnkd.in/eK2MC-ma

We are looking forward to meeting biopharma dealmaking colleagues in Malaga! #ipls #dealmaking #biopharma #partnering #swisshlg

🚀We are excited to announce the launch of our new Swiss HLG website!🚀    🌟Our team has been working for the last few months to deliver a fresh modern website. We aimed to make it more appealing, helpful and intuitive so that you can enjoy the best possible user experience!🌟 💻 www.swisshlg.com 💻

📌SAVE THE DATE!📌 Flagship Conference 2025 The Swiss HLG 23rd annual conference will be held on 25th - 27th May 2025 once again at the historic Belle Epoque Grand Hotel Suisse Majestic in the beautiful scenic location of Montreux, Switzerland. #swisshlg #swisshlgconference #biopharma #dealmaking #innovation #networking

📢We have some exciting news: Join us for our annual after work networking event in Swiss Romandie in collaboration with Biopôle Lausanne and BioAlps - Swiss Health Valley on October 3rd at Biopôle in Lausanne. 🗣️There will be a panel presentation on Negotiations: Aligning Stakeholders for Success and a discussion with representatives from start-up, academia, pharma and venture capital followed by a networking apero. 👉Register here ➡ https://lnkd.in/eHiJuaFb #negotiation #stakeholders #success  #networking #swisshlg #bdl #partnering #healthcare #entrepreneur #biotech #collaboration #businessdevelopment #Negotiations #opportunity #network #venturecapital #startup #pharma #academia

We held the second Swiss HLG Start-Up Initiative workshop on June 12, kindly hosted by Johnson & Johnson at their new campus in Allschwil. This initiative is a collaboration between Swiss HLG, BaseLaunch and Johnson & Johnson and aims to help 30 great biotech start-ups get Fit for Partnering through a series of four linked workshops. At the June workshop nine brave start-ups pitched to an expert jury, including Johnson & Johnson, Novartis, Roche, Pureos Bioventures and Forty51 Ventures. We are enormously grateful for the thoughtful insights provided by Anthony Gemmell, Markus Werner, Alessandra Polara, Ying Wang, Anne Grahl and Sara Núñez-Garcia, PhD, MBA. And big thanks to our Board member Michael R Huebner for being a fantastic organiser and host. The quality of the pitches was impressive and we would like to thank the wonderful start-ups for pitching: - Amporin Pharmaceuticals - Antion Biosciences SA - Ariya Bio - Barrier Therapeutics - T-Oncology AG - ILONOV - MT-act - Selmod - FatiAbGen Inc. It was a fantastic event with a great atmosphere and we are keenly looking forward to the next workshop in September, which will dive into partnering and term sheet negotiations.

A picture from a recent face to face Board meeting kindly hosted by our suporter IQVIA in Basel. We were delighted to welcome Lambert Potin to his first meeting after joining the Board. We reviewed feedback from our recent annual conference - very positive - and started to plan the 2025 edition. Save the date, it will be on May 25th-27th 2025 back in beautiful Montreux! Other topics included: - Local networking events - our 2024 Romandie event is on October 3rd in Lausanne, and we also plan one in the North West - Our next webinar coming up on November 7th - The imminent launch of our refreshed website - Feedback from the Swiss HLG Start-Up Initiative pitching event kindly hosted by Johnson & Johnson, with a great expert panel including Johnson & Johnson, Novartis, Roche, Pureos Bioventures, and Forty51 Ventures and support from BaseLaunch. The next workshop in September will dive into partnering and term sheet negotiations. So as we head off for summer vacations, we are happy to look forward to an exciting roster of events for when we all return. Please join us!

We have some exciting news: Swiss HLG would like to extend a warm welcome to our new board member Lambert Potin, joining us from our valued long term supporter, Debiopharm. Lambert holds a BSc, MSc and PhD in Life Sciences from EPFL in Lausanne. He also conducted academic research in the field of cancer and immunology at the University of Chicago for 5 years. During his time in Chicago, he also worked for a year as a Venture Capital Associate at the George Shultz Innovation Fund, focusing on early-stage biotech investments. He relocated back to Lausanne as a Life sciences consultant for Alcimed. In this role, he conducted innovation, scientific and strategy projects in the life sciences. Since 2020, he has been working within the Search & Evaluation team at Debiopharm, mostly on in-licensing transactions. He is also a board observer in a VC-backed biotech company in the San Francisco Bay area. Lambert`s comments ¨I am proud to join a stellar team of dealmakers within the Swiss HLG Board and I look forward to contributing my experience and network to the broader healthcare business development community.¨